In our research, we demonstrated that the proliferation and invasion-promoting capabilities of ARRB1-△exon13 in GBM cells could be partially inhibited by 2-DG, attributed to its role in limiting glucose uptake [30]. The gene discussed is ARRB1; the disease is glioblastoma.